Fig. 7

Construction and validation of the prognostic model in R_cancer group. A LASSO coefficient profiles of DEGs. B Selection of the optimal parameter (lambda) in the LASSO model. C Differences in overall survival between high-risk and low-risk groups based on the risk scores in R_cancer patients. D Time-dependent ROC curves in the train set at 1-year, 2-year, 3-year, 5-year, 7-year, and all-year in R_cancer patients. E Time-dependent ROC curves in the test set at 1-year, 2-year, 3-year, 5-year, 7-year, and all-year in R_cancer patients. F The ROC curves of Five-fold cross-validation in R_cancer patients. G–L Comparison of survival rates of high-risk and low-risk groups in different clinical subtypes in R_cancer patients. Survival analysis of different clinical characteristics including G Age < 65, H Age ≥ 65, I Female, J Male, K Stage I-II, L Stage III-IV